Follow the Bausch & Lomb Corp stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Bausch & Lomb Corp has logged 210 insider filings. Market capitalisation: €6bn. The latest transaction was reported on 14 August 2026 (Attribution). Among the most active insiders: Munsch Frederick. All data is free.
210
Insider Decl.
n/a
Thresholds
€2m
12 ops.
Buy Volume
€641m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bausch & Lomb Corp Buy (bullish), based on 12 analysts. Average price target: US$18.63.
41Σ signal
Buys €2m€641m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,307 of 29,024 companies
27.8
score / 100
Value
25
Quality
31
FCF yld-1.1%
Earn yld-5.9%
EV/EBITDA21.3x
ROE-2.5%
Gross mgn60%
Net mgn-7.1%
Debt/EBITDA9.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,842 shares@ US$15.780.0037% mcap57.3% of flowCommon Shares, No Par ValueSEC:0001860742-26-000079:0
25 of 210 declarations
About Bausch & Lomb Corp
Bausch & Lomb Corp is a company focused on eye care, providing products such as contact lenses and care solutions. It is listed on NASDAQ under the ticker BLCO.